Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07EAB
|
|||
Former ID |
DNC007293
|
|||
Drug Name |
1-(4-nonylbenzyl)pyrrolidine-3-carboxylic acid
|
|||
Synonyms |
CHEMBL224703; 570423-46-0; 1-(4-nonylbenzyl)pyrrolidine-3-carboxylic acid; SCHEMBL6179612; CTK1F3134; DTXSID10436795; BDBM50158343; AKOS030543683; 3-Pyrrolidinecarboxylic acid, 1-[(4-nonylphenyl)methyl]-
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C21H33NO2
|
|||
Canonical SMILES |
CCCCCCCCCC1=CC=C(C=C1)CN2CCC(C2)C(=O)O
|
|||
InChI |
1S/C21H33NO2/c1-2-3-4-5-6-7-8-9-18-10-12-19(13-11-18)16-22-15-14-20(17-22)21(23)24/h10-13,20H,2-9,14-17H2,1H3,(H,23,24)
|
|||
InChIKey |
JXGNTXCFTVWCAS-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 570423-46-0
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sphingosine-1-phosphate receptor 1 (S1PR1) | Target Info | Inhibitor | [1] |
KEGG Pathway | FoxO signaling pathway | |||
Sphingolipid signaling pathway | ||||
Neuroactive ligand-receptor interaction | ||||
NetPath Pathway | IL4 Signaling Pathway | |||
TGF_beta_Receptor Signaling Pathway | ||||
IL2 Signaling Pathway | ||||
Pathway Interaction Database | Fc-epsilon receptor I signaling in mast cells | |||
S1P3 pathway | ||||
S1P1 pathway | ||||
Sphingosine 1-phosphate (S1P) pathway | ||||
PDGFR-beta signaling pathway | ||||
Reactome | G alpha (i) signalling events | |||
Lysosphingolipid and LPA receptors | ||||
WikiPathways | Signal Transduction of S1P Receptor | |||
Small Ligand GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
GPCRs, Other |
References | Top | |||
---|---|---|---|---|
REF 1 | A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 re... J Med Chem. 2004 Dec 30;47(27):6662-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.